AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28403475 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete abstinence from smoking
Number of subjects: 381
Study 28403475 — intervention group
Group type: COMPARATOR
Intervention: Smoking > 0 < 5 cpd
Number of subjects: 381
Study 28403475 — intervention group
Group type: COMPARATOR
Intervention: Smoking 5-9 cpd
Number of subjects: 381
Study 28403475 — intervention group
Group type: COMPARATOR
Intervention: Smoking ≥10 cpd
Number of subjects: 381
Study 25677337 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconscious thought condition (participants were distracted for 3 minutes)
Number of subjects: 173
Study 25677337 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconscious thought condition
Number of subjects: 173
Study 25677337 — intervention group
Group type: COMPARATOR
Intervention: Conscious thought condition (participants instructed to think about the information for 3 minutes)
Number of subjects: 173
Study 25677337 — intervention group
Group type: COMPARATOR
Intervention: Immediate decision condition (participants moved directly to the decision task)
Number of subjects: 173
Study 24315811 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm newborns (n=22) reaching term age (38-42 weeks)
Number of subjects: 47
Study 24315811 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (term newborns)
Number of subjects: 47
Study 24315811 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm newborns (first EEG)
Number of subjects: 47
Study 21840129 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 0
Study 21840129 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal vasopressin (AVP)
Number of subjects: 0
Study 21840129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19123933 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 2900
Study 19123933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2900
Study 19123933 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 2900
Study 18173093 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (6.2 g/day)
Number of subjects: 109
Study 18173093 — intervention group
Group type: COMPARATOR
Intervention: Sorbitol/maltitol (control)
Number of subjects: 109
Study 15133882 — intervention group
Group type: EXPERIMENTAL
Intervention: Management intervention programs
Number of subjects: 0
Study 15133882 — intervention group
Group type: COMPARATOR
Intervention: Reference group of matched physicians
Number of subjects: 0
Study 12031189 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition science college course (n = 21)
Number of subjects: 40
Study 12031189 — intervention group
Group type: COMPARATOR
Intervention: Control group (no course, n = 19)
Number of subjects: 40
Study 9674374 — intervention group
Group type: EXPERIMENTAL
Intervention: Amended instructions linking direction instructions to landmarks
Number of subjects: 80
Study 9674374 — intervention group
Group type: COMPARATOR
Intervention: Full guidance instructions
Number of subjects: 80
Study 9674374 — intervention group
Group type: COMPARATOR
Intervention: No guidance instructions
Number of subjects: 80
Study 9674374 — intervention group
Group type: COMPARATOR
Intervention: Driving experience of 1 year or less
Number of subjects: 80
Study 8018401 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy with doxorubicin
Number of subjects: 111
Study 8018401 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-based chemotherapy without doxorubicin
Number of subjects: 111
Study 8018401 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy
Number of subjects: 111
Study 2644855 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg ferrous sulfate twice daily for 16 weeks
Number of subjects: 0
Study 2644855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1115173 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone-releasing IUD
Number of subjects: 201
Study 1115173 — intervention group
Group type: COMPARATOR
Intervention: Non-steroid IUD
Number of subjects: 201
Study 31800355 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 176
Study 31800355 — intervention group
Group type: COMPARATOR
Intervention: 0.5% hydroxypropyl‐methylcellulose (control)
Number of subjects: 176
Study 31220698 — intervention group
Group type: EXPERIMENTAL
Intervention: Light sleep
Number of subjects: 149
Study 31220698 — intervention group
Group type: COMPARATOR
Intervention: Wakefulness
Number of subjects: 149
Study 31220698 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispectral EEG index during light sleep
Number of subjects: 149
Study 28035868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily for 24 weeks
Number of subjects: 381
Study 28035868 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 24 weeks
Number of subjects: 381
Study 25885266 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision-support reminders for medical providers
Number of subjects: 0
Study 25885266 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 0
Study 23639513 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine fixed-dose combination (OA)
Number of subjects: 141
Study 23639513 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine double dose (DA)
Number of subjects: 141
Study 21525201 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight suppression
Number of subjects: 91
Study 21525201 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppressed resting metabolic rate (RMR)
Number of subjects: 91
Study 21525201 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppressed total energy expenditure (TEE)
Number of subjects: 91
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: Bassini repair
Number of subjects: 365
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: Shouldice repair
Number of subjects: 365
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: Lichtenstein repair
Number of subjects: 365
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPP
Number of subjects: 365
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 365
Study 18283518 — intervention group
Group type: COMPARATOR
Intervention: Open techniques (Bassini, Shouldice, Lichtenstein)
Number of subjects: 365
Study 18283518 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic techniques (TAPP, TEP)
Number of subjects: 365
Study 18283518 — intervention group
Group type: COMPARATOR
Intervention: Mesh techniques (Lichtenstein, TAPP, TEP)
Number of subjects: 365
Study 18283518 — intervention group
Group type: COMPARATOR
Intervention: Suturing techniques (Bassini, Shouldice)
Number of subjects: 365
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative complications
Number of subjects: 365
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative complications
Number of subjects: 365
Study 18283518 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term complications
Number of subjects: 365
Study 16948487 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training and nutritional counseling (n = 25)
Number of subjects: 51
Study 16948487 — intervention group
Group type: COMPARATOR
Intervention: Strength training only (n = 26)
Number of subjects: 51
Study 16948487 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 51
Study 16948487 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counseling
Number of subjects: 51
Study 16948487 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training and nutritional counseling
Number of subjects: 51
Study 12716247 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium augmentation (LA)
Number of subjects: 44
Study 12716247 — intervention group
Group type: COMPARATOR
Intervention: Cognitive therapy (CT)
Number of subjects: 44
Study 10836195 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic gestodene (Minulet)
Number of subjects: 2419
Study 10836195 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic gestodene (Tri‐Minulet)
Number of subjects: 2419
Study 10836195 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic desogestrel (Mercilon)
Number of subjects: 2419
Study 10836195 — intervention group
Group type: COMPARATOR
Intervention: Desogestrel (Mercilon)
Number of subjects: 2419
Study 9109072 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ketorolac tromethamine (Acular) in the multiple-drop group
Number of subjects: 30
Study 9109072 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac sodium (Voltaren) in the multiple-drop group
Number of subjects: 30
Study 9109072 — intervention group
Group type: COMPARATOR
Intervention: 0.5% ketorolac tromethamine (Acular) in the two-drop group
Number of subjects: 30
Study 9109072 — intervention group
Group type: COMPARATOR
Intervention: 0.1% diclofenac sodium (Voltaren) in the two-drop group
Number of subjects: 30
Study 1394532 — intervention group
Group type: EXPERIMENTAL
Intervention: Betoptic
Number of subjects: 10
Study 1394532 — intervention group
Group type: COMPARATOR
Intervention: Timoptol
Number of subjects: 10
Study 1394532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3900975 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg q.o.d.)
Number of subjects: 22071
Study 3900975 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (50 mg q.o.d.)
Number of subjects: 22071
Study 3900975 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for both interventions)
Number of subjects: 22071
Study 31803192 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 25
Study 31803192 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 25
Study 31803192 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil
Number of subjects: 25
Study 29075849 — intervention group
Group type: EXPERIMENTAL
Intervention: Paleolithic-type diet (PD)
Number of subjects: 58
Study 27311399 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT) with level V lymphatics (LVN) included
Number of subjects: 408
Study 27311399 — intervention group
Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT) with level V lymphatics (LVN) omitted
Number of subjects: 408
Study 24650400 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonculprit MBG 0/1
Number of subjects: 6921
Study 24650400 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonculprit MBG 0/1 with TIMI flow grade 3 in culprit vessel
Number of subjects: 6921
Study 22205035 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency percussive ventilation (HFPV)
Number of subjects: 35
Study 22205035 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 35
Study 20103391 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan program
Number of subjects: 28
Study 20103391 — intervention group
Group type: COMPARATOR
Intervention: Balance training program
Number of subjects: 28
Study 18005381 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous PCA with remifentanil
Number of subjects: 52
Study 18005381 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia with 20 ml levobupivacaine 0.625 mg/ml and fentanyl 2 microg/ml
Number of subjects: 52
Study 16099291 — intervention group
Group type: EXPERIMENTAL
Intervention: C4A-rich plasma priming (20 mL/kg)
Number of subjects: 116
Study 16099291 — intervention group
Group type: COMPARATOR
Intervention: C4A-free plasma priming (20 mL/kg)
Number of subjects: 116
Study 16099291 — intervention group
Group type: COMPARATOR
Intervention: C4A-free plasma priming
Number of subjects: 116
Study 16099291 — intervention group
Group type: EXPERIMENTAL
Intervention: C4A-rich plasma priming
Number of subjects: 116
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal delivery with third- or fourth-degree perineal tears
Number of subjects: 949
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: Forceps delivery
Number of subjects: 949
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: Anal sphincter tears
Number of subjects: 949
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: First vaginal birth
Number of subjects: 949
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: Median episiotomy
Number of subjects: 949
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-assisted delivery
Number of subjects: 949
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth weight 4000 g or more
Number of subjects: 949
Study 11868640 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of the second stage of labour 1.5 hours or longer
Number of subjects: 949
Study 10837909 — intervention group
Group type: EXPERIMENTAL
Intervention: DIABNET decision support system
Number of subjects: 9
Study 8732492 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 8
Study 8732492 — intervention group
Group type: EXPERIMENTAL
Intervention: D-arginine
Number of subjects: 8
Study 8732492 — intervention group
Group type: EXPERIMENTAL
Intervention: L-lysine
Number of subjects: 8
Study 8732492 — intervention group
Group type: EXPERIMENTAL
Intervention: D-lysine
Number of subjects: 8
Study 8732492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornithine
Number of subjects: 8
Study 8732492 — intervention group
Group type: COMPARATOR
Intervention: Hyperosmolar sodium chloride
Number of subjects: 8
Study 1553671 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg trinitroglycerine patches
Number of subjects: 81
Study 1553671 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 81
Study 2991171 — intervention group
Group type: EXPERIMENTAL
Intervention: Extruded whole-grain product
Number of subjects: 9
Study 2991171 — intervention group
Group type: COMPARATOR
Intervention: Baked whole-grain wheat bread
Number of subjects: 9
Study 2991171 — intervention group
Group type: COMPARATOR
Intervention: White bread
Number of subjects: 9
Study 2991171 — intervention group
Group type: COMPARATOR
Intervention: Extruded crispbread-like products (white and whole-grain)
Number of subjects: 9
Study 31087715 — intervention group
Group type: EXPERIMENTAL
Intervention: Any antibiotics use
Number of subjects: 2484
Study 31087715 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics for respiratory infections
Number of subjects: 2484
Study 31087715 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics for urinary tract infections
Number of subjects: 2484
Study 31087715 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics for skin and soft tissue infections
Number of subjects: 2484
Study 31087715 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-lactamase sensitive penicillin (more than two prescriptions)
Number of subjects: 2484
Study 29161674 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subcallosal cingulate gyrus (SCG)
Number of subjects: 8
Study 29161674 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 8
Study 27648792 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice/gel pack cryotherapy wrap
Number of subjects: 100
Study 27648792 — intervention group
Group type: COMPARATOR
Intervention: Circulating cold water cryotherapy device
Number of subjects: 100
Study 23489253 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/daily)
Number of subjects: 22
Study 23489253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 21762564 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional chest physical therapy (CCPT)
Number of subjects: 280
Study 21762564 — intervention group
Group type: COMPARATOR
Intervention: High-frequency chest wall compressions (HFCWC)
Number of subjects: 280
Study 21762564 — intervention group
Group type: COMPARATOR
Intervention: Both CCPT and HFCWC
Number of subjects: 280
Study 20466215 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoPulse‐CPR
Number of subjects: 0
Study 20466215 — intervention group
Group type: COMPARATOR
Intervention: manual‐CPR
Number of subjects: 0
Study 18249290 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionator
Number of subjects: 208
Study 18249290 — intervention group
Group type: EXPERIMENTAL
Intervention: Headgear/Bite Plane
Number of subjects: 208
Study 18249290 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 208
Study 16182705 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Kidney Graft (SKG)
Number of subjects: 60
Study 16182705 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual Kidney Graft (DKG)
Number of subjects: 60
Study 10556650 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with psoriasis
Number of subjects: 34
Study 10556650 — intervention group
Group type: COMPARATOR
Intervention: Healthy age‐matched controls
Number of subjects: 34
Study 8907098 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 264
Study 8907098 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 264
Study 29683498 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF
Number of subjects: 40
Study 29683498 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF+FDBA
Number of subjects: 40
Study 29683498 — intervention group
Group type: EXPERIMENTAL
Intervention: FDBA
Number of subjects: 40
Study 29683498 — intervention group
Group type: COMPARATOR
Intervention: Blood clot
Number of subjects: 40
Study 25787020 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (mean 43 ± 12 mg/day)
Number of subjects: 62
Study 25787020 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 24411152 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 22
Study 24411152 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 22
Study 24223343 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 104
Study 24223343 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 8 mg
Number of subjects: 104
Study 20160397 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/day pioglitazone for 12 weeks
Number of subjects: 50
Study 20160397 — intervention group
Group type: COMPARATOR
Intervention: 500 mg/day metformin for 12 weeks
Number of subjects: 50
Study 17089155 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave diathermy treatment (passive hyperthermia) increasing muscle temperature to over 40 degrees C, 16-20 hours prior to exercise.
Number of subjects: 15
Study 17089155 — intervention group
Group type: COMPARATOR
Intervention: Control arm (untreated)
Number of subjects: 15
Study 16307999 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 30
Study 16307999 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 30
Study 12219338 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-information booklet (SIB) with paroxetine (Group A)
Number of subjects: 84
Study 12219338 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine alone (Group B)
Number of subjects: 84
Study 9459227 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 44
Study 9459227 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 44
Study 9459227 — intervention group
Group type: COMPARATOR
Intervention: Control (fentanyl and midazolam)
Number of subjects: 44
Study 7876412 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct resin composite (DC) veneer restorations
Number of subjects: 0
Study 7876412 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect resin composite (IC) veneer restorations
Number of subjects: 0
Study 7876412 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcelain (P) veneer restorations
Number of subjects: 0
Study 2404033 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% chlorhexidine
Number of subjects: 10
Study 2404033 — intervention group
Group type: COMPARATOR
Intervention: water
Number of subjects: 10
Study 351488 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 93
Study 351488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 30796001 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding
Number of subjects: 80
Study 30796001 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting
Number of subjects: 80
Study 30796001 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 80
Study 30796001 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl methacrylate application
Number of subjects: 80
Study 30796001 — intervention group
Group type: COMPARATOR
Intervention: Polycarbonate groups (all treatment methods)
Number of subjects: 80
Study 30796001 — intervention group
Group type: COMPARATOR
Intervention: PMMA groups (all treatment methods)
Number of subjects: 80
Study 30796001 — intervention group
Group type: EXPERIMENTAL
Intervention: Both crown materials
Number of subjects: 80
Study 29020247 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterolane maleate (AM) 37.5 mg and piperaquine phosphate (PQP) 187.5 mg once daily for 3 days
Number of subjects: 859
Study 29020247 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) twice daily for 3 days
Number of subjects: 859
Study 29020247 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterolane maleate (AM) and piperaquine phosphate (PQP)
Number of subjects: 859
Study 29020247 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 859
Study 24854088 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (clobetasol propionate 0.05% ointment) applied for the first 2 days, followed by petrolatum jelly for the rest of the week.
Number of subjects: 40
Study 24854088 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum jelly applied for 7 days (control group).
Number of subjects: 40
Study 24854088 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum jelly (control group).
Number of subjects: 40
Study 23829026 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring critical signals with separated displays
Number of subjects: 0
Study 23829026 — intervention group
Group type: COMPARATOR
Intervention: Monitoring critical signals with split-screen displays
Number of subjects: 0